Rau And Co Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 35.00 Cr
- Satisfied Charges ₹ 21.88 Cr
- Revenue Growth 4.97%
- Profit Growth 64.58%
- Ebitda 58.25%
- Net Worth -20.66%
- Total Assets 12.38%
About Rau And Co Pharma
Rau And Co Pharma Private Limited (RACPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2016 (Eight years and 11 months 14 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹35.00 Cr. The company has closed loans amounting to ₹21.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivasa Manickam, Sanjeevi Gurugopi, and Varun Mehta serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51109TN2016PTC104216
-
Company No.
104216
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Feb 2016
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Rau And Co Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Manickam
|
Director | 27-Feb-2023 | Current |
|
Sanjeevi Gurugopi
|
Director | 21-Oct-2021 | Current |
| Varun Mehta | Director | 10-Jul-2024 | Current |
Financial Performance of Rau And Co Pharma.
Rau And Co Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.97% increase. The company also saw a substantial improvement in profitability, with a 64.58% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rau And Co Pharma?
In 2020, Rau And Co Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shell Pharmaceuticals Private LimitedSrinivasa Manickam and Varun Mehta are mutual person
-
Muthu Pharma Private LimitedSrinivasa Manickam and Varun Mehta are mutual person
-
Pearl Medicals Private Limited
Srinivasa Manickam and Varun Mehta are mutual person
Charges (Loans)
₹350.00 M
₹218.80 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 35.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Oct 2019 | Axis Bank Limited | ₹35.00 Cr | Open |
| 07 Dec 2017 | Others | ₹10.38 Cr | Satisfied |
| 11 Jul 2017 | Hdfc Bank Limited | ₹6.50 Cr | Satisfied |
| 05 Jul 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 Cr | Satisfied |
How Many Employees Work at Rau And Co Pharma?
Rau And Co Pharma has a workforce of 26 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rau And Co Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rau And Co Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
